Allakos Inc. operates as a clinical stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.

Allakos Inc

Allakos Inc. operates as a clinical stage biopharmaceutical company.

Should you buy, sell, or hold Allakos Inc (ALLK) ?

Allakos Inc (ALLK) : Buy or Sell